27 Apr 2023 , 03:29 PM
The initial public offer of Mankind Pharma is largely backed by qualified institutional investors who bought 29,42,95,469 equity shares out of 80,11,769 shares reserved at 3.15 PM on final day of the offer. The retail portion was booked 0.77 times while non-institutional investors’ portion is booked 3.62 times.
The company has kept the price band between Rs 1,026 – 1,080 per share. And Mankind pharma is expecting to raise Rs 4,326 crore with this IPO.
The pharmaceutical firm has reserved half of its issue size for QIBs, 15% for high-networth individuals and the remaining 35% for retail investors.
Mankind Pharma IPO important details
| Open date | April 25 |
| Close date | April 27 |
| Lot size | 13 |
| IPO size (Rs crore) | Rs 4,326.36 Cr |
| IPO price range (Rs) | Rs 1026-1080 per share |
| Minimum investment | Rs 14,040 |
| Basis of allotment date | May 3 |
| Refunds date | May 4 |
| Credit to demat account date | May 5 |
| Listing date | May 8 |
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
